Selective COX-2 inhibitors are widely used in the treatment of analgesic, anti-inflammatory, and antithrombotic (26), but its higher dose and long term use tightly associated with the myocardial infarction, atherosclerosis, heart failure and stroke (6). The gene discussed is PTGS2; the disease is heart failure.